Professor Jin Shi's Experience in Treating Rheumatoid Arthritis with A Secondary Osteoporosis by Benefiting the Kidney and Unblocking the Collaterals
-
摘要: 类风湿性关节炎是临床常见的慢性全身免疫性疾病, 金实教授认为该病始于先天肾精亏虚, 长期病程中因气血化生乏源,运行不畅, 滋生凝痰败瘀, 药物使用及肢体残疾亦会加重这一本虚标实之证。骨络是运行气血的细微结构, 常因气血虚弱而发生虚损, 亦易为凝痰败瘀所痹阻; 骨络功能缺失, 骨髓失以濡养, 以致骨枯髓减, 从而继发骨质疏松症。金实教授以肾精亏虚、骨络痹阻为类风湿性关节炎继发骨质疏松症的核心病机, 采用益肾通络的治则治法进行遣方用药, 取得了较好的临床疗效。Abstract: Rheumatoid arthritis is a common chronic systemic immune disease. Professor Jin Shi believes that the disease begins with congenital deficiency of kidney essence. After the long course of the disease, the lack of production and transformation source of qi and blood can lead to the poor qi movement and blood circulation. As the condition gets worse, it will breed pathogenic phlegm and stasis. Besides, excessive drug use and physical disability can also exacerbate the disease, which is deficiency in root and excess in manifestation. Bones and collaterals are the delicate structures for running qi and blood, which are often weakened by qi- and blood-deficiency. In addition, they are easily paralyzed by pathogenic phlegm and stasis. The disfunction of bones and collaterals can lead to bone marrow malnutrition, further resulting in bone withering and marrow reduction, and thus leading to osteoporosis. Professor Jin Shi took the deficiency of kidney essence, combined with paralysis and obstruction of bone and collaterals as the core pathogenesis of rheumatoid arthritis with a secondary osteoporosis. Therefore, when the treatment method of benefiting kidney and unblocking the collaterals is applied clinically, a better therapeutic effect can be achieved.
-
[1] 卢敏辉, 郭娟, 张清, 等. 唑来膦酸治疗风湿病合并骨质疏松患者70例临床观察[J]. 风湿病与关节炎, 2021, 10(8): 19-23, 46.LU MH, GUO J, ZHANG Q, et al. Clinical observation of zoledronic acid in the treatment of 70 patients with rheumatism and osteoporosis[J]. Rheum Arthritis, 2021, 10(8): 19-23, 46. [2] 陈辉阳, 陈凯, 陈海鹏. 中医药治疗绝经后骨质疏松症的研究进展[J]. 中医药临床杂志, 2020, 32(3): 572-576.CHEN HY, CHEN K, CHEN HP. Research progress on the treatment of postmenopausal osteoporosis with traditional Chinese medicine[J]. Clin J Tradit Chin Med, 2020, 32(3): 572-576. [3] 陈镜, 冯正平. 骨质疏松症治疗药物研究进展[J]. 中国骨质疏松杂志, 2021, 27(5): 776-780. doi: 10.3969/j.issn.1006-7108.2021.05.029CHEN J, FENG ZP. Research progress of the therapeutic drugs for osteoporosis[J]. Chin J Osteoporos, 2021, 27(5): 776-780. doi: 10.3969/j.issn.1006-7108.2021.05.029 [4] FRANCO HL, NAGARI A, KRAUS WL. TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome[J]. Mol Cell, 2015, 58(1): 21-34. doi: 10.1016/j.molcel.2015.02.001 [5] 黄祺, 朱圣炜, 程海燕, 等. 绝经后2型糖尿病妇女骨质疏松与颈动脉粥样斑块关系的初探[J]. 中国骨质疏松杂志, 2016, 22(1): 72-75.HUANG Q, ZHU SW, CHENG HY, et al. Correlation between atherosclerosis and osteoporosis in postmenopausal women with type 2 diabetes[J]. Chin J Osteoporos, 2016, 22(1): 72-75. [6] 曹君君. 中医治疗老年类风湿性关节炎继发骨质疏松症的临床效果[J]. 保健文汇, 2020(12): 47-48.CAO JJ. Clinical effect of treating osteoporosis secondary to senile rheumatoid arthritis with traditional Chinese medicine[J]. Health Lit, 2020(12): 47-48. [7] 闵文, 周龙云, 黄桂成, 等. 黄桂成教授运用络病理论治疗骨关节炎学术思想探讨[J]. 四川中医, 2018, 6(8): 8-10.MIN W, ZHOU LY, HUANG GC, et al. Discussion on professor Huang guicheng's academic thought of application of collateral disease theory on treating osteoarthritis[J]. J Sichuan Tradit Chin Med, 2018, 36(8): 8-10. [8] 王剑, 丰雪妮, 刘剑辉, 等. 补肾健骨中药复方对去卵巢骨质疏松症大鼠骨组织Leptin启动子甲基化的影响[J]. 中国骨质疏松杂志, 2021, 27(5): 668-672, 688.WANG J, FENG XN, LIU JH, et al. Effect of reinforcing kidney to strengthen bone Chinese herbal compound on methylation of leptin promoter in bone of ovariectomized osteoporosis rats[J]. Chin J Osteoporos, 2021, 27(5): 668-672, 688. [9] 黄帝内经素问[M]. 太原: 山西科学技术出版社, 2017.The Yellow Emperor's Inner Classic: Basic Questions[M]. Taiyuan: Shanxi scientific & technical publishers, 2017. [10] 王肯堂. 证治准绳[M]. 北京: 人民卫生出版社, 2014: 323.WANG KT. Standards for Diagnosis and Treatment[M]. Beijing: People's medical publishing house, 2014: 323. [11] 灵枢经[M]. 北京: 中国医药科技出版社, 2011: 71, 109.The Spiritual Pivot[M]. Beijing: China medical science press, 2011: 71, 109. [12] 叶天士. 临证指南医案[M]. 北京: 华夏出版社, 1995: 402.YE TS. Case Records as A Guide to Clinical Practice[M]. Beijing: Huaxia publishing house, 1995: 402. [13] 高士栻. 医学真传[M]. 天津: 天津科学技术出版社, 2000: 43.GAO SS. True Transmission of Medicine[M]. Tianjin: Tianjin scientific & technical publishers, 2000: 43.
点击查看大图
计量
- 文章访问数: 168
- HTML全文浏览量: 20
- PDF下载量: 19
- 被引次数: 0